Aisha A. Alsfouk

1.6k total citations
92 papers, 1.3k citations indexed

About

Aisha A. Alsfouk is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Aisha A. Alsfouk has authored 92 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Organic Chemistry, 45 papers in Molecular Biology and 25 papers in Computational Theory and Mathematics. Recurrent topics in Aisha A. Alsfouk's work include Synthesis and biological activity (35 papers), Computational Drug Discovery Methods (25 papers) and Cancer therapeutics and mechanisms (17 papers). Aisha A. Alsfouk is often cited by papers focused on Synthesis and biological activity (35 papers), Computational Drug Discovery Methods (25 papers) and Cancer therapeutics and mechanisms (17 papers). Aisha A. Alsfouk collaborates with scholars based in Saudi Arabia, Egypt and Indonesia. Aisha A. Alsfouk's co-authors include Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly, Hazem Elkady, Ibrahim M. Ibrahim, Dalal Z. Husein, Reda G. Yousef, Mohamed S. Alesawy, Mohammed S. Taghour and Mohamed M. Khalifa and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Aisha A. Alsfouk

85 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aisha A. Alsfouk Saudi Arabia	19	696	662	265	201	189	92	1.3k
Tarfah Al‐Warhi Saudi Arabia	25	1.1k 1.5×	802 1.2×	156 0.6×	222 1.1×	115 0.6×	59	1.8k
Hamada S. Abulkhair Egypt	34	1.5k 2.2×	902 1.4×	296 1.1×	291 1.4×	194 1.0×	68	2.2k
Mamdouh F. A. Mohamed Egypt	22	950 1.4×	597 0.9×	117 0.4×	146 0.7×	109 0.6×	58	1.4k
Mohamed S. Alesawy Egypt	15	495 0.7×	367 0.6×	165 0.6×	132 0.7×	118 0.6×	21	785
Hany E. A. Ahmed Saudi Arabia	29	1.2k 1.7×	680 1.0×	239 0.9×	150 0.7×	82 0.4×	66	1.8k
Hazem Elkady Egypt	30	1.5k 2.1×	1.3k 1.9×	350 1.3×	443 2.2×	454 2.4×	94	2.3k
N. Jeelan Basha India	19	559 0.8×	457 0.7×	160 0.6×	173 0.9×	105 0.6×	29	1.1k
Hamed I. Ali Egypt	27	786 1.1×	675 1.0×	157 0.6×	141 0.7×	93 0.5×	60	1.6k
Sahar M. Abou‐Seri Egypt	32	2.1k 3.0×	1.2k 1.8×	223 0.8×	279 1.4×	193 1.0×	69	2.6k
Mostafa A. Elhendawy Egypt	13	626 0.9×	444 0.7×	117 0.4×	123 0.6×	162 0.9×	20	950

Countries citing papers authored by Aisha A. Alsfouk

Since Specialization

Citations

This map shows the geographic impact of Aisha A. Alsfouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha A. Alsfouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha A. Alsfouk more than expected).

Fields of papers citing papers by Aisha A. Alsfouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisha A. Alsfouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha A. Alsfouk. The network helps show where Aisha A. Alsfouk may publish in the future.

Co-authorship network of co-authors of Aisha A. Alsfouk

This figure shows the co-authorship network connecting the top 25 collaborators of Aisha A. Alsfouk. A scholar is included among the top collaborators of Aisha A. Alsfouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisha A. Alsfouk. Aisha A. Alsfouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eissa, Ibrahim H., Alaa Elwan, Dalal Z. Husein, et al.. (2025). Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors. RSC Advances. 15(17). 12896–12916. 6 indexed citations

Elkaeed, Eslam B., Hazem Elkady, Reda G. Yousef, et al.. (2025). Development of novel furan-based VEGFR-2 inhibitors and apoptotic inducers for colorectal cancer. Future Medicinal Chemistry. 17(24). 2959–2973.

Elkady, Hazem, Hazem A. Mahdy, Mohammed S. Taghour, et al.. (2024). New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(6). 130599–130599. 13 indexed citations

Eissa, Ibrahim H., Hazem Elkady, Walid E. Elgammal, et al.. (2024). Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2. Journal of Molecular Structure. 1312. 138641–138641. 13 indexed citations

Alsfouk, Aisha A., Ismail M. M. Othman, Manal M. Anwar, et al.. (2024). Synthesis and computational studies of new pyridine, pyrazole, pyran, and pyranopyrimidine-based derivatives of potential antimicrobial activity as DNA gyrase and topoisomerase IV inhibitors. Journal of Molecular Structure. 1319. 139528–139528. 13 indexed citations

Mahdy, Hazem A., Hazem Elkady, Walid E. Elgammal, et al.. (2024). Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers. Journal of Molecular Structure. 1316. 139019–139019. 15 indexed citations

Bender, Onur, İsmail Çeli̇k, Amer Ali Abd El‐Hafeez, et al.. (2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals. 17(5). 659–659. 4 indexed citations

Riley, Christopher M., Usama M. Ammar, Aisha A. Alsfouk, et al.. (2024). Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-b]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB Signalling. Molecules. 29(15). 3515–3515. 5 indexed citations

Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, et al.. (2023). A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies. ChemistryOpen. 12(10). e202300066–e202300066. 11 indexed citations

10.

Elgammal, Walid E., Hazem Elkady, Hazem A. Mahdy, et al.. (2023). Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC Advances. 13(51). 35853–35876. 20 indexed citations

11.

Channar, Pervaiz Ali, Syeda Abida Ejaz, Aisha A. Alsfouk, et al.. (2023). Synthesis, Single Crystal XRD, In-Silico and In-Vitro Studies of Alkyl Substituted Acyl Thiourea as Carbonic Anhydrase Inhibitor. Journal of Molecular Structure. 1292. 136187–136187. 8 indexed citations

12.

Elwan, Alaa, Abdallah E. Abdallah, Hazem A. Mahdy, et al.. (2022). Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation. Molecules. 27(15). 5047–5047. 51 indexed citations

13.

Фазылов, С. Д., et al.. (2022). Combined Computational and Experimental Studies of Anabasine Encapsulation by Beta-Cyclodextrin. Plants. 11(17). 2283–2283. 9 indexed citations

14.

Фазылов, С. Д., et al.. (2022). Combined In Silico and Experimental Investigations of Resveratrol Encapsulation by Beta-Cyclodextrin. Plants. 11(13). 1678–1678. 15 indexed citations

15.

Elkaeed, Eslam B., Mohamed M. Khalifa, Bshra A. Alsfouk, et al.. (2022). The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites. 12(11). 1122–1122. 10 indexed citations

16.

Elkaeed, Eslam B., Ibrahim H. Eissa, Hazem Elkady, et al.. (2022). A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease. International Journal of Molecular Sciences. 23(15). 8407–8407. 44 indexed citations

17.

Yousef, Reda G., Mohamed M. Khalifa, Wagdy M. Eldehna, et al.. (2022). Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1389–1403. 45 indexed citations

18.

Taghour, Mohammed S., Hazem A. Mahdy, Alaa Elwan, et al.. (2022). Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2063–2077. 43 indexed citations

19.

Elkaeed, Eslam B., Fadia S. Youssef, Ibrahim H. Eissa, et al.. (2022). Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. International Journal of Molecular Sciences. 23(13). 6912–6912. 52 indexed citations

20.

Eissa, Ibrahim H., Mohamed M. Khalifa, Eslam B. Elkaeed, et al.. (2021). In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 26(20). 6151–6151. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact